TLDR
- CoreWeave stock dropped 3.4% to $83.53, hitting an intraday low of $79.46, with trading volume down 20% from its average session
- Wall Street maintains a Moderate Buy consensus with an average price target of $135, with some targets as high as $250
- Meta’s potential entry into the AI cloud/compute market is spooking investors, raising concerns about long-term competition for CoreWeave
- Insiders have sold over $3 billion worth of CRWV stock in the past 90 days, though most sales are tied to pre-arranged tax withholding plans
- CoreWeave missed Q1 earnings estimates, posting EPS of -$1.40 vs the expected -$1.17, though revenue surged 111.6% year-over-year to $2.08 billion
CoreWeave (CRWV) dropped 3.4% on Tuesday, trading at $83.53 after dipping as low as $79.46 intraday. The stock had closed the prior session at $86.46.
CoreWeave, Inc. Class A Common Stock, CRWV
Volume came in at roughly 23 million, about 20% below the stock’s average session pace — suggesting the move wasn’t driven by a surge of panic selling.
The stock is up 26% year-to-date but down 41% over the past year, sitting well below its 50-day moving average of $106.86.
The day’s decline came against a backdrop of growing investor concern around two fronts: Meta’s push into AI compute, and a steady stream of insider selling.
A Bloomberg report flagged that Meta is considering selling AI computing power and raw computing capacity to outside customers — a move that would put it in direct competition with CoreWeave’s core business.
Rosenblatt maintained its Buy rating and kept a $250 price target, arguing the Meta threat is overstated. Wolfe Research and Evercore ISI both reiterated Outperform ratings with $150 price targets.
Insider Selling Under the Microscope
Insider sales have caught attention. In the past 90 days, insiders have sold over $3 billion worth of CRWV stock.
Most recently, General Counsel Kristen J. McVeety sold 22 shares for $1,889 on July 6, under a Rule 10b5-1 plan adopted in May 2025.
Earlier, insider Brian Venturo sold 76,912 shares on July 1 at an average of $86.99, totaling roughly $6.69 million. That represented a 21% reduction in his position.
Insider Brannin McBee sold 56,707 shares on June 30 at $95.69, for about $5.43 million — a 14.9% cut to his stake.
Both sales were executed under pre-arranged Rule 10b5-1 plans to cover tax obligations on vesting equity. That’s a routine mechanism, but the scale has still drawn scrutiny.
Earnings Miss Still Fresh
CoreWeave’s last earnings report, from May 7, didn’t help sentiment. The company posted EPS of -$1.40, missing the -$1.17 consensus by $0.23.
Revenue hit $2.08 billion, up 111.6% year-over-year. Strong top-line growth, but the profitability gap remains wide — net margin sits at -25.57%.
Analysts on average forecast full-year EPS of -$4.57.
Despite the miss, several analysts argued the selloff is overdone. BNP Paribas has the highest price target on the Street at $192, while Cantor Fitzgerald sits at $167. Wells Fargo raised its target to $155 in May.
Out of 35 analysts covering the stock, 21 rate it a Buy, 12 a Hold, and 2 a Sell.
The company’s debt-to-equity ratio stands at 3.68, with a current ratio of just 0.31 — a balance sheet that carries real risk alongside the growth story.
CoreWeave’s market cap sits at approximately $37–45 billion, depending on the session. It launched ARIA, an AI-enabled research agent, this week — though analysts don’t see it as a near-term market mover.
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.







